Carmat SA (EPA:ALCAR)

France flag France · Delayed Price · Currency is EUR
0.0990
0.00 (0.00%)
At close: Mar 6, 2026
-88.81%
Market Cap 6.15M
Revenue (ttm) 7.34M
Net Income (ttm) -51.40M
Shares Out 62.08M
EPS (ttm) -1.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open n/a
Previous Close 0.0990
Day's Range n/a
52-Week Range 0.0850 - 0.9500
Beta 1.02
RSI 27.64
Earnings Date Apr 8, 2026

About Carmat

Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2008
Employees 153
Stock Exchange Euronext Paris
Ticker Symbol ALCAR
Full Company Profile

Financial Performance

In 2024, Carmat's revenue was 7.34 million, an increase of 91.40% compared to the previous year's 3.84 million. Losses were -51.40 million, -4.59% less than in 2023.

Financial Statements

News

There is no news available yet.